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Abstract
Introduction: Flexible ureteroscopy (fURS) is increasingly used in the treatment of renal stones. However,
wide variations exist in technique, use, and indications. To better inform our knowledge about the contemporary
state of fURS for treating renal stones, we conducted a survey of endourologists worldwide.
Methods: An anonymous online questionnaire assessing fURS treatment of renal stones, consisting of 36 items,
was sent to members of the Endourology Society in October 2014. Responses were collected through the
SurveyMonkey system over a 3-month period.
Results: Questionnaires were answered by 414 surgeons from 44 countries (response rate 20.7%). U.S. surgeons
accounted for 34.4% of all respondents. fURS was routinely performed in 80.0% of institutions, with 40.0% of
surgeons performing >100 cases/year. Respondents considered fURS to be first-line therapy for patients with renal
stones <2 cm and lower pole calculi. A substantial minority (11.3%) preferred fURS as a primary treatment
modality for renal stones >2 cm. Basket displacement for lower pole stones was routinely performed by 55.8%.
Ureteral access sheaths (UAS) were preferred for every case by 58.3%. Respondents frequently utilized high-power
lasers and dusting techniques. Criteria for determining stone-free rate were defined as zero fragments or residual
fragment (RF) <1, <2, <3, and <4mm by 30.9%, 8.9%, 31.5%, 15.8%, and 11.2% of respondents, respectively.
Conclusion: The overwhelming majority of endourologists surveyed consider fURS as a first-line treatment mo-
dality for renal stones, especially those <2 cm. Use of UAS, high-power holmium lasers, and dusting technique has
become popular among practitioners. When defining stone free after fURS, the majority of endourologists used a
zero fragment or RF <2mm definition.
Introduction
Treatment options for patients with renal stonesmainly comprise one of three procedures: percutaneous
nephrolithotomy (PCNL), shockwave lithotripsy (SWL), and
flexible ureteroscopy (fURS). The ability to use the holmium
laser to perform intracorporeal lithotripsy, as well as advances
in endoscope technology and ancillary instrumentation, has
seen fURS emerge as an increasingly popular method for
managing patients with upper urinary-tract stones. In the
United States, newly qualified urologists are increasingly
using URS for the majority of stone removal procedures.1
Despite recent population-level evidence demonstrating
increasing utilization of fURS,2–4 little information exists on
contemporary practice patterns of fURS for the treatment of
renal calculi.5 While guidelines recommend fURS for treating
renal stones <1.5 cm,6 considerable differences exists among
urologists in the technique, use, and indications of fURS. In
particular, the variation in the use of disposable equipment,
such as ureteral access sheaths (UAS) or nitinol retrieval de-
vices, and the utilization of more powerful high-watt holmium
laser systems in the modern era of fURS, have not been
thoroughly evaluated. Recently, the European Association of
Urology (EAU) conducted a survey on the use of fURS for the
treatment of renal calculi in Europe.5 To study a broader col-
lection of urologists throughout the world, we modified this
questionnaire and surveyed members of the Endourology So-
ciety about multiple facets of renal calculi treatment using
fURS. Our specific aimwas to explore differences in the fURS
technique and practice among endourologists.
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Methods
In October 2014, an anonymous online questionnaire
characterizing fURS use in the management of renal stones
was disseminated to all members of the Endourology Society
through e-mail. The survey instrument contained 36 discrete
questions divided into six domains to capture demographic
information, level of surgeon experience, indications, surgi-
cal technique, postoperative stent management and tracking,
and postsurgical follow-up. Questions were multiple choice
with the option for free text responses. See Appendix for
details on questions asked. Respondents were further sub-
divided based on region of residence for descriptive purposes
such that those from North America, Europe, and other re-
gions could be compared with respect to various responses.
The survey was conducted using the web-based Survey-
Monkey system (Palo Alto, CA). Respondents were invited to
participate through an introductory email from the En-
dourology Society membership office with a brief description
of the survey and a hyperlink of the survey. A second reminder
e-mail was sent a month later and the survey remained open for
3 months. The survey was deemed exempt from requiring re-
view by the Institutional Review Board at the University of
Michigan. To improve participation, a $200 award was offered
to one respondent selected at random. The studywas funded by
the Endourology Division of the Department of Urology,
University of Michigan.
Results
The survey was disseminated to *2000 members of the
Endourology Society; 414 (20.7%) responded. Those re-
sponding represented 44 countries with the largest percentage
of respondents practicing in the United States (34.4%),
United Kingdom (9.8%), and Canada (5.3%) (Table 1). More
than 60% of respondents were between the ages of 40 and 59;
2% were <30 years, 23% were between 30 and 39 and 14%
were older than 60 years. Approximately 60% of respondents
had completed an endourology fellowship, while 80.5% in-
dicated they were a subspecialist with an interest in urinary
stone disease.
The case volume of fURS performed annually is depicted
in Figure 1; nearly 40% of respondents performed fURSmore
than 100 times per year. fURS was performed routinely in the
institution of 80% of respondents.
Indications and planning
With regard to indications and surgical planning, respon-
dents overwhelmingly (96.4%) felt that fURS could be used
as a first-line modality to treat renal stones. To this effect,
there was a wide range of clinical situations in which re-
spondents felt that fURS was an appropriate primary treat-
ment, the most popular being stone in horsehoe kidney
(72.1%) and stone in the lower pole (71%) (Fig. 2). Patients
were considered for staged fURS (more than one URS
planned in advance) when the renal stone size (cm) was 1–1.5
(9.7%), >1.5 (20.2%), >2.0 (27.0%), and >2.5 (16.3%).
Surgical technique
When examining techniques, there was variability in the
way urologists approached the ureteral orifice before advanc-
ing the ureteroscope. Whereas some placed working and/or
safety wires (38.0%), others first performed semirigid ur-
eteroscopy (19.7%), retrograde pyelogram (14.6%), or placed
a UAS (25.7%). Only 1.9% of respondents performed fURS
without a wire.
In the event that the ureteroscope was unable to be ad-
vanced beyond the ureteral orifice, 27.6% of respondents
stated they would dilate the orifice with ureteral dilators,
27.4% stated they would dilate with a semirigid ureteroscope,
25.5% stated they would place a ureteral stent and arrange for
fURS at a later date, 18.2%would perform balloon dilation of
the ureteral orifice, 1.1% would switch to another treatment
modality, and 0.2% would perform a ureterotomy.
UAS/basket retrieval
Indications for use of UAS during fURS are provided in
Figure 3, with 58.3% of respondents stating that they prefer to
Table 1. Distribution of Urologists Responding
to Survey on Flexible Ureteroscopy
Country Respondents (N) Percent
Argentina 3 0.8
Australia 4 1.1
Bangladesh 1 0.3
Belgium 3 0.8
Brazil 11 3.1
Bulgaria 2 0.6
Canada 19 5.3
Chile 3 0.8
China 10 2.8
Colombia 8 2.2
Egypt 3 0.8
El Salvador 1 0.3
France 6 1.7
Germany 13 3.6
Greece 5 1.4
India 14 3.9
Indonesia 1 0.3
Iran 4 1.1
Ireland 1 0.3
Israel 1 0.3
Italy 9 2.5
Japan 11 3.1
Lithuania 4 1.1
Mexico 8 2.2
Netherlands 6 1.7
Nigeria 1 0.3
Norway 2 0.6
Pakistan 2 0.6
Philippines 3 0.8
Portugal 1 0.3
Romania 1 0.3
Russia 6 1.7
Saudi Arabia 3 0.8
Singapore 4 1.1
South Africa 7 1.9
South Korea 2 0.6
Spain 7 1.9
Thailand 1 0.3
Turkey 8 2.2
United Arab Emirates 1 0.3
United Kingdom 35 9.7
United States 123 34.3
Venezuela 1 0.3
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use a UAS for every case. With regard to the strategy of
whether to retrieve stone fragments or not, 26.7% of re-
spondents actively retrieved all stone fragments, whereas
37.4% only retrieved large fragments—leaving those that
were small enough to pass spontaneously (Fig. 4). When
dealing with stones in the lower pole, most (55.8%) routinely
used the basket displacement technique to move stones to a
less dependent calix for fragmentation.
Holmium laser
Respondents uniformly utilized a holmium laser for stone
fragmentation, and the vast majority worked in centers that
owned their own laser (85.6%). High-power systems
(‡100W) were utilized by 41.1%, while lower power (20–
30W) systems were used by 44.2%. The majority of re-
spondents (54.8%) preferred a 200-lm laser fiber size as their
go to fiber. The dusting technique (i.e., low pulse energy and
high frequency 0.2–0.5 J · 30–50Hz) was used by 67% of the
respondents.
Postprocedural aspects
Respondents indicated that in their practice, following
completion of fURS, a ureteral stent was placed in all cases
63.9% of the time, whereas the remainder stated that a ureteral
stent was only placed if warranted by intraoperative factors.
Only 42.8% of respondents indicated that their practice
maintained a stent registry to keep track of indwelling stents in
patients (Fig. 5). Finally, respondents indicated that an ab-
dominal radiograph, in combination with ultrasonography
(40.8%), abdominal radiograph alone (32.8%), computed to-
mography (24.7%), or ultrasound alone (1.7%), was used to
assess stone burden following fURS. The time point at which
imaging was undertaken to assess the stone-free rate (SFR)
varied (Fig. 6). Table 2 demonstrates the variation among
urologists for determining what fragment size is important for
defining the SFR.
Variation in technique by geographic location
After subdividing respondents by location of residence
(North America, Europe, other), differences were noted with
regard to selected questions as indicated in Table 3.
Discussion
The present survey-based study was conducted to better
understand the worldwide variation in the fURS technique
and clinical practice. In summary, the majority of urologists
who responded were fellowship trained andmany estimated a
volume of more than 100 procedures performed annually.
Most respondents felt fURS was applicable to a wide range of
clinical scenarios, including varying stone size, stone loca-
tion, and anatomic variations. Furthermore, respondents
routinely used UAS and were familiar with high-watt hol-
mium lasers for fURS, as well as using new techniques such
as dusting for stone fragmentation.
One interesting observation highlighted by the survey re-
sults was that urologists find fURS to be an acceptable sur-
gical technique for a wide range of indications. Recent EAU
guidelines state that fURS is a reasonable option for treatment
of renal stones <2 cm. In the present study, more than 10% of
respondents indicated that fURS was considered an appro-
priate treatment for stones >2 cm, a size that traditionally
FIG. 1. Number of flexible ureteroscopies (fURS) per-
formed annually.
FIG. 2. Clinical scenarios in which fURS is appropriate
first-line treatment for renal stones.
FIG. 3. Indications for ureteral access sheath during fURS.
FIG. 4. Responses to the questions ‘‘Regarding fragmen-
tation of a stone and whether to retrieve fragments or not,
what is your typical strategy?’’
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would be managed through PCNL. Moreover, despite a
nonstatistical difference in SFRs reported in the prospective
randomized controlled study comparing SWL with uretero-
scopy for lower pole stones <1 cm, 71% of respondents felt
fURS was the first-line therapy in this situation.7
Two recent studies have demonstrated that fURS is a
reasonable approach for renal stones >2 cm. In a meta-
analyses of urinary stones >2 cm managed by fURS, Abou-
marzouk et al. found that for a mean stone size of 2.5 cm,
SFRs were 93.7% with a major complication rate of 5.3%.8 A
similar study by Breda and Angerri for stones >2.5 cm
showed an overall SFR of 89.3% with a major complication
rate of 8%.9 The average number of treatments required per
patient was 1.6 in each study. These studies highlight that the
combination of technologic advances and endourologic ex-
pertise may be broadening the application of fURS, a clinical
impression reflected by our survey.
Another observation made from our study was the fre-
quency with which surgeons utilized the UAS.More than half
of respondents indicated in the survey that they used a UAS
for every case, whereas an additional 25% used it in selected
clinical scenarios. Advantages of the UAS include improving
longevity of the flexible ureteroscope10 as well as decreasing
intrarenal pressure during fURS.11 The UAS is often used to
ease stone retrieval, as noted by 31.0% of respondents. De-
spite these benefits, outcomes such as SFR, arguably one of
the most important indicators of effective fURS, have shown
mixed results. L’esperance et al. evaluated 256 patients un-
dergoing fURS for renal calculi stratifying outcomes based
on whether a UAS was used or not. The SFR in the UAS
group was 79%, significantly higher than the non-UAS group
(67%).12 However, a more recent study did not find use of a
UAS to be associated with improved SFRs with stone size
being the only variable predictive of SFR on regression
analysis.13 The paucity of evidence is reflected in the varia-
tion of use by respondents in our survey.
Our study provided some interesting findings with respect
to practice patterns surrounding active stone retrieval vs
fragmentation. Specifically, many respondents actively re-
trieved stone fragments and only a few indicated that they
seek to fragment the stone into pieces they feel will pass
spontaneously, without any need for extraction. Certainly,
debate regarding the optimal fragmentation and retrieval
technique has been ongoing.14 Currently, no Level 1 evi-
dence is available that answers the following question:
‘‘should you perform active retrieval or is fragmentation only
enough after fURS for renal stones?’’ More recently, newer
laser lithotripsy techniques such as dusting utilizing high-
watt holmium systems have been popularized.15 Dusting uses
a high-frequency, low-pulse energy setting, such as 30–
50Hz · 0.2–0.5 J, which seeks to fragment stones to fine
powder and small fragments, and thus reduce the need to
retrieve fragments. We were surprised to find out that two-
thirds of respondents indicated using this technique. So far,
there are limited clinical data as to whether this method has
significant advantages over existing techniques, and further
studies are needed to confirm its utility.
Interestingly, more than 63% of respondents indicated that
a ureteral stent was left in place following fURS. There have
been numerous clinical trials conducted to investigate the
utility of routine ureteral stenting following ureteroscopy. A
recent systematic review and meta-analysis by Nabi et al.
found that patients in whom a ureteral stent was placed re-
ported higher rates of dysuria, urgency, and frequency
without a statistically significant increased SFR, although
this was limited by study heterogeneity.16 Given the uncer-
tainty on this issue and lack of improvement in SFR reported
in the meta-analysis, it is notable that so many respondents
routinely stent their patients following fURS.
Our study has also provided some important information on
determining the preferred method and criteria for determining
the SFR after fURS. Approximately 75% used an abdominal
radiograph, renal ultrasound, or a combination of the two as the
imaging modality of choice for assessing residual stone bur-
den. Most respondents use to perform this within 6 weeks
following surgery. Certainly, use of ultrasound following URS
is encouraged to rule out silent hydronephrosis, which can
occur in up to 2%–5% of patients.17–19 Less agreed upon,
however, is the definition of SFR following fURS. The term
clinically insignificant residual fragment (RF) was introduced
FIG. 5. Strategies for ureteral stentmanagement and tracking.
FIG. 6. Time point after fURS when stone-free status is
determined.
Table 2. Residual Fragment Size Considered
to Be Stone Free
Fragment size (mm) Respondent (N) Percent
Zero fragments 108 30.9
<1 31 8.9
<2 110 31.5
<3 55 15.8
<4 39 11.2
<5 6 1.7
1224 DAUW ET AL.
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for asymptomatic noninfectious RFs <4–5mm following
SWL, andmany studies adopted thismetricwhen reporting the
success of stone treatment.20 However, recent computed
tomography-based studies have shown that instead of RF
£4mm, sizes £2 or £3mm might be more appropriate for de-
termining the clinical significance of stone free and risk of
retreatment after stone surgery.21,22 The lack of consensus in
our field about imaging utilization and criteria23 is demon-
strated in our study where nearly 30% felt stone free was de-
fined as zero fragments on imaging, whereas the remainder felt
RF <1–4mm was appropriate.
Two prior surveys have investigated practice patterns
surrounding upper tract urinary stone treatment use among
urologists.24,25 Bandi et al. surveyed members of the North
Central Section of the American Urological Association in
2006 and found that fURS was largely reserved for proximal
and distal ureteral calculi. Subcentimeter renal stones were
largely managed with SWL, whereas larger stones were
managed with PCNL. This is in contrast to our study, where
upward of 90% of urologists indicated fURS an appropriate
first-line therapy for renal calculi of varying sizes and loca-
tion. Our results are similar to a recent EAU survey con-
ducted by Sanguedolce et al. wherein 95% of surveyed
urologists preferred fURS as first-line therapy for renal cal-
culi for a variety of clinical scenarios, and where also use of
UAS was prevalent.5 Unlike our study, the EAU survey did
not assess the use of holmium laser systems or practice pat-
terns on postprocedure imaging and criteria for SFR.
The results of our study are useful in that they depict the
demographics and practice patterns of an experienced group
of specialty-trained urologists. However, certain limitations
must be acknowledged. First, this study represents a highly
specialized cohort of urologists, and thus, the findings may
not be generalizable to general urologists without specialty
training in endourology. In addition, our survey response
rate of 21% is suboptimal and may influence the generaliz-
ability of our results. Furthermore, due to a general lack of
rigorous level-one evidence regarding the benefit of several
techniques described in the article (UAS use and dusting),
observations from respondents serve more as descriptive
findings rather than evidence of appropriate use. Moreover,
the cost implications of technologic innovation with lack of
proven benefit outside of observational studies must be
considered carefully when treating patients with renal stones.
Finally, there is always the possibility that due to reporting
bias, opinions reflected in this survey do not necessarily
mirror clinical practice. Nevertheless, our study response rate
is similar to prior endourology surveys,24 and even higher
than more recent ones to Endourology Society members.25
Finally, it is possible that some urologists may not be fully
aware how best to utilize the holmium laser power settings,
and further survey-based studies are needed to verify our
findings.
Conclusion
The use of fURS for treating renal calculi has expanded
such that it is considered first-line therapy by endourologists
for varying stone sizes, stone locations, and anatomical var-
iations. UAS, high-power holmium lasers, and dusting
technique are now utilized on a regular basis. When defining
stone-free status after fURS, the majority of urologists sur-
veyed used a zero fragment or RF <2mm definition. Al-
though there is consensus regarding certain aspects of fURS
technique and practice, several controversies still exist that
merit further investigation.
Table 3. Variation in Region of Practice and Techniques
USA/Canada Europe Other
Do you consider UAS use during fURS?(Q15)
UAS used for every case (%) 46.9 53.7 75.2
What is your main reason for UAS use? (Q17)
UAS used for stone retrieval (%) 47.2 21.5 20.2
What is your strategy to remove stone fragments? (Q20)
Only remove large fragments (%) 36.0 28.4 46.6
All fragments removed regardless of size (%) 34.4 27.4 22.0
What is your laser power? (Q22)
100W (%) 45.2 26.1 37.4
Do you perform dusting (high frequency/low pulse energy)? (Q26)
Yes (%) 65.9 73.1 64.0
What imaging do you use to assess stone-free status? (Q34)
KUB XR if stone is radiopaque (%) 35.5 34.4 25.7
KUB XR and US if stone is radiopaque (%) 24.2 30.1 23.9
At what point do you assess stone-free status postsurgery?
6 weeks (%) 32.5 12.0 22.9
1 month (%) 30.9 27.2 28.1
How do you define stone-free status? (Q36)
No fragments (%) 41.1 32.7 21.9
<2mm fragments (%) 33.9 28.3 31.6
For some questions, the two most common responses are provided for comparative assessment.
fURS = flexible ureteroscopy; KUB = kidney, ureter, and bladder radiograph; UAS = ureteral access sheaths; XR=X-ray; US = ultrasound.
PRACTICE PATTERNS IN URETEROSCOPY 1225
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Appendix—Survey Instrument
Question 1: What practice is your practice located in?
Question 2: How old are you?
Question 3: Do you have fellowship training in endourology/stones?
Question 4: Which of the following would you consider yourself?
 General urologist
 Urologist with specialty interest in stone disease
 Urologist with specialty interest in another area
Question 5: Approximately how often is flexible ureteroscopy used to treat renal stones at your center?
 Never
 Infrequently
 Sometimes
 Routinely
Question 6: Approximately how many flexible ureteroscopies to treat renal stones do you perform per year?
 0
 <10
 10–20
 20–50
 50–100
 >100
Question 7: If you do not perform flexible ureteroscopy for renal stones please select why not.
 Access to equipment
 Prefer different treatment modality
 Urolithiasis is not my specialty
 Other (explain)
Question 8: Do you think flexible ureteroscopy to treat renal stones can be considered a first-line procedure in specific
cases?
 Yes
 No
Question 9: In which scenarios would you use flexible ureteroscopy to treat a stone?
 Lower pole stone
 Renal stone <1 cm
 Renal stone 1–2 cm
 Renal stone >2 cm
 Stone in caliceal diverticulum
 Stone in pelvic kidney
 Stone in horseshoe kidney
 Other
Question 10: When do you consider a patient for staged flexible ureteroscopy to treat renal calculi?
 Total renal stone burden 1–1.5 cm
 Total renal stone burden >1.5 cm
 Total renal stone burden >2 cm
 Total renal stone burden >2.5 cm
 I don’t perform staged procedures
Question 11: What steps do you typically perform before advancing a flexible ureteroscope?
 I place a working wire first
 I place a working and safety wire first
 I perform semirigid ureteroscopy first
 I place a ureteral access sheath first
 I perform a retrograde pyelogram first
 I perform flexible ureteroscopy without any wire
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Question 12: If you are unable to advance a flexible scope beyond the ureteral orifice, which of the following procedures
do you perform first?
 I perform passive dilation with ureteral dilator(s)
 I perform active dilation with a balloon dilator
 I perform a ureterotomy
 I place a ureteral stent and arrange for flexible ureteroscopy later
 I perform dilation with semirigid ureteroscopy
 I prefer to switch to another treatment option
Question 13: If you are able to advance flexible scope beyond the ureteral orifice but then unable to advance beyond the
lower ureter, which of the following procedures do you perform first?
 I perform passive dilation with ureteral dilator(s)
 I perform active dilation with a balloon dilator
 I perform a ureterotomy
 I place a ureteral stent and arrange for flexible ureteroscopy later
 I perform dilation with semirigid ureteroscopy
 I prefer to switch to another treatment option
Question 14: How do you routinely advance the flexible ureteroscope into the kidney?
 Under fluoroscopic control
 Under direct vision
 Under fluoroscopic control and direct vision
Question 15: How do you consider the use of the ureteral access sheath during flexible ureteroscopy
for treating renal stones? (Select all that apply)
 I prefer it for each case
 Only if large stone burden
 Only if ureter is prestented
 Only if aim is to proceed with active stone retrieval
 Never used
 Other
Question 16: Which size of ureteral access sheath (UAS) do you typically use (in nonstented ureter)?
 9.5–11.5F
 10–12F
 11–13F
 12–14F
 13–15F
 14–16F
Question 17: What is your main reason for using a UAS?
 To keep pressure in the collecting system low
 To perform retrieval of stone
 For better vision and irrigation
 It is easier to perform flexible ureteroscopy with this
Question 18: When inserting a UAS, what wire do you use for its placement?
 polytetrafluoroethylene (PTFE) wire
 Hydrophilic wire
 Hybrid wire
 Super-stiff wire
Question 19: When dealing with lower pole renal stones, what strategy do you follow?
 I prefer to displace the stone to a less dependent area with a nitinol basket
and start fragmentation in a new area
 I prefer to start the fragmentation of the stone in situ in the lower pole
 Indifferent, I can retrieve the stone or not according to the situation
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Question 20: Regarding fragmentation of a stone and whether to retrieve fragments or not,
what is your typical strategy?
 I actively retrieve all fragments with a nitinol basket
 I retrieve only the bigger fragments with a nitinol basket and leave those that I think
are small enough to pass spontaneously
 I don’t retrieve any fragments. I perform fragmentation of the stone until I think all the fragments
are small enough to pass spontaneously
 I retrieve depending on the stone size and location
 I retrieve only in patients with prestented ureters
 I retrieve only when stone is difficult to fragment into small bits or if anatomy
is unsuitable for fragment passage
Question 21: Does your center/practice have access to a holmium laser for ureteroscopic lithotripsy?
Question 22: What power is your holmium laser?
 20W
 30W
 50W
 60–80W
 100W
 120W
Question 23: Is your laser ___________________?
 Owned by center
 Leased but always on-site
 Leased and comes to center from outside as needed
Question 24: What is your standard ‘‘go to’’ laser fiber size when treating a renal stone?
 150 fiber
 200 fiber
 270 fiber
 365 fiber
 depends on location
Question 25: What is your standard setting on the holmium laser for stone fragmentation?
 0.5–1.0 J · 5–10Hz
 0.5–1.0 J · 10–15Hz
 0.5–1.0 J · 15–20Hz
 1.0–1.5 J · 5–10Hz
 1.0–1.5 J · 10–15Hz
 1.0–1.5 J · 15–20Hz
 0.2–0.4 J · 30–50Hz
 0.5 · 20–50Hz
 no standard setting; it varies with the situation
 other
Question 26: Do you use Dusting settings at all (i.e., Low Pulse Energy, High frequency 0.2–0.5 J3 30–50Hz)?
Question 27: At the end of a routine flexible ureterorenoscopy to treat renal calculi
 I place a ureteral stent to be removed in the office at a later date
 I place an open-ended ureteral catheter, to be removed in 24 to 48 hours
 I don’t place a stent or ureteral catheter
 Whether or not I stent depends on intraoperative factors (time of surgery, residual fragments, ureteral injury, etc.)
 I place a stent to be removed by patient at home (stent on string)
Question 28: Do you ever use stent on string placement after flexible ureterorenoscopy to treat renal stones?
 Never
 Occasionally
 Routinely
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Question 29: How many days is the maximum time you will instruct your patient to keep the stent (on a string)?
 1 day
 2 days
 3 days
 4 days
 5 days
 >7 days
 It depends on the situation
Question 30: Do you or your center/practice maintain a ureteral stent registry to keep track and recall stents in patients?
Question 31: What method is used to keep track of stents?
 Paper-based system: managed by physician
 Paper-based system: managed by administrative assistant(s)
 Electronic stent registry integrated with electronic patient record
 Electronic stent registry that is not integrated with electronic patient record
 Other
Question 32: Have you ever failed to remove a ureteral stent in timely manner with consequences of patient morbidity?
Question 33: Have you ever managed a patient who had a forgotten ureteral stent?
Question 34: Which imaging modality do you use to determine stone free after flexible ureterorenoscopy?
 Kidney, ureter, and bladder radiograph (KUB) X-ray (XR) if stone radiopaque
 Ultrasound scan if stone is radiolucent
 KUB XR if radiopaque and ultrasound scan
 Ultrasound scan only regardless of stone lucency
 Non contrast CT of abdomen/pelvis
 Low-dose noncontrast CT of abdomen/pelvis
Question 35: At what time point do you assess stone-free rate after flexible ureterorenoscopy treatment for renal
stones?
 2 weeks
 1 month
 6 weeks
 2 months
 3 months
 6 months
Question 36: What are the important stone size criteria for you when determining if a patient is stone-free?
 Patient must have zero fragments to be stone free
 <1mm fragment is OK
 <2mm fragment is OK
 <3mm fragment is OK
 <4mm fragment is OK
 <5mm fragment is OK
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